BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 18838474)

  • 21. Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study.
    Rigacci L; Puccini B; Dodero A; Iacopino P; Castagna L; Bramanti S; Ciceri F; Fanin R; Rambaldi A; Falda M; Milone G; Guidi S; Martelli MF; Mazza P; Oneto R; Bosi A;
    Ann Hematol; 2012 Jun; 91(6):931-9. PubMed ID: 22245922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High rate of long-term survival for high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy.
    Espigado I; Ríos E; Marín-Niebla A; Carmona M; Parody R; Pérez-Hurtado JM; Márquez FJ; Urbano-Ispizua A
    Transplant Proc; 2008 Nov; 40(9):3104-5. PubMed ID: 19010208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study.
    Martín A; Conde E; Arnan M; Canales MA; Deben G; Sancho JM; Andreu R; Salar A; García-Sanchez P; Vázquez L; Nistal S; Requena MJ; Donato EM; González JA; León A; Ruiz C; Grande C; González-Barca E; Caballero MD;
    Haematologica; 2008 Dec; 93(12):1829-36. PubMed ID: 18945747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis.
    Kumar SK; Dingli D; Lacy MQ; Dispenzieri A; Hayman SR; Buadi FK; Rajkumar SV; Litzow MR; Gertz MA
    Am J Hematol; 2008 Aug; 83(8):614-7. PubMed ID: 18429054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation Registry.
    van Kampen RJ; Canals C; Schouten HC; Nagler A; Thomson KJ; Vernant JP; Buzyn A; Boogaerts MA; Luan JJ; Maury S; Milpied NJ; Jouet JP; Ossenkoppele GJ; Sureda A
    J Clin Oncol; 2011 Apr; 29(10):1342-8. PubMed ID: 21321299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma.
    Porrata LF; Ristow K; Habermann TM; Witzig TE; Inwards DJ; Markovic SN
    Am J Hematol; 2009 Feb; 84(2):93-7. PubMed ID: 19123458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [5 years of dosage intensification and autologous bone marrow or peripheral stem cell transfusion in malignant lymphoma with a high risk of recurrence].
    Jost LM; Pichert G; Reichlin M; Müller E; Jacky E; Honegger HP; Gmür J; Stahel RA
    Schweiz Med Wochenschr; 1993 May; 123(18):932-40. PubMed ID: 8098878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune Disease.
    Tyndall A; Fassas A; Passweg J; Ruiz de Elvira C; Attal M; Brooks P; Black C; Durez P; Finke J; Forman S; Fouillard L; Furst D; Holmes J; Joske D; Jouet J; Kötter I; Locatelli F; Prentice H; Marmont AM; McSweeney P; Musso M; Peter HH; Snowden JA; Sullivan K; Gratwohl A
    Bone Marrow Transplant; 1999 Oct; 24(7):729-34. PubMed ID: 10516675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: long-term disease control and toxicity.
    Hoppe BS; Moskowitz CH; Filippa DA; Moskowitz CS; Kewalramani T; Zelenetz AD; Yahalom J
    J Clin Oncol; 2008 Apr; 26(11):1858-64. PubMed ID: 18332466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of progressive disease after autologous stem cell transplantation in patients with non-Hodgkin's lymphoma: a nation-wide survey.
    Kuittinen T; Wiklund T; Remes K; Elonen E; Lehtinen T; Kuittinen O; Leppä S; Putkonen M; Räty R; Turpeenniemi-Hujanen T; Nousiainen T; Jantunen E
    Eur J Haematol; 2005 Sep; 75(3):199-205. PubMed ID: 16104875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma.
    Costa LJ; Micallef IN; Inwards DJ; Johnston PB; Porrata LF; Litzow MR; Ansell SM
    Br J Haematol; 2008 Oct; 143(2):268-73. PubMed ID: 18699848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does follicularity in large cell lymphoma predict outcome after autologous stem cell transplantation?
    Krishnan A; Nademanee A; Fung H; Angelopoulou M; Molina A; Gaal K; Dagis A; Palmer J; Alvarnas J; Slovak M; Kogut N; Popplewell L; Rodriguez R; Schriber J; Wang S; Forman SJ
    Biol Blood Marrow Transplant; 2006 Jun; 12(6):641-7. PubMed ID: 16737937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma.
    Buadi FK; Micallef IN; Ansell SM; Porrata LF; Dispenzieri A; Elliot MA; Gastineau DA; Gertz MA; Lacy MQ; Litzow MR; Tefferi A; Inwards DJ
    Bone Marrow Transplant; 2006 Jun; 37(11):1017-22. PubMed ID: 16633361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Multiple autologous transplantations with intermediate-dose melphalan for two elderly patients with relapsed or refractory diffuse large B-cell lymphoma].
    Nishimoto T; Hatanaka K; Matsuoka A; Ueda K; Yonetani N; Tamaki T
    Rinsho Ketsueki; 2009 Dec; 50(12):1720-4. PubMed ID: 20068281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation.
    Rodrigues CA; Sanz G; Brunstein CG; Sanz J; Wagner JE; Renaud M; de Lima M; Cairo MS; Fürst S; Rio B; Dalley C; Carreras E; Harousseau JL; Mohty M; Taveira D; Dreger P; Sureda A; Gluckman E; Rocha V
    J Clin Oncol; 2009 Jan; 27(2):256-63. PubMed ID: 19064984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation.
    Kyriakou C; Canals C; Finke J; Kobbe G; Harousseau JL; Kolb HJ; Novitzky N; Goldstone AH; Sureda A; Schmitz N
    J Clin Oncol; 2009 Aug; 27(24):3951-8. PubMed ID: 19620487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose chemotherapy with autologous stem cell transplantation for elderly patients with relapsed/refractory diffuse large B cell lymphoma: a nationwide retrospective study.
    Chihara D; Izutsu K; Kondo E; Sakai R; Mizuta S; Yokoyama K; Kaneko H; Kato K; Hasegawa Y; Chou T; Sugahara H; Henzan H; Sakamaki H; Suzuki R; Suzumiya J
    Biol Blood Marrow Transplant; 2014 May; 20(5):684-9. PubMed ID: 24492141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autologous stem cell transplantation in multiple myeloma patients <60 vs >/=60 years of age.
    Reece DE; Bredeson C; Pérez WS; Jagannath S; Zhang MJ; Ballen KK; Elfenbein GJ; Freytes CO; Gale RP; Gertz MA; Gibson J; Giralt SA; Keating A; Kyle RA; Maharaj D; Marcellus D; McCarthy PL; Milone GA; Nimer SD; Pavlovsky S; To LB; Weisdorf DJ; Wiernik PH; Wingard JR; Vesole DH
    Bone Marrow Transplant; 2003 Dec; 32(12):1135-43. PubMed ID: 14647267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conditional survival of patients with diffuse large B-cell lymphoma.
    Moller MB; Pedersen NT; Christensen BE
    Cancer; 2006 May; 106(10):2165-70. PubMed ID: 16586498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990-1999.
    Pedrazzoli P; Ferrante P; Kulekci A; Schiavo R; De Giorgi U; Carminati O; Marangolo M; Demirer T; Siena S; Rosti G;
    Bone Marrow Transplant; 2003 Sep; 32(5):489-94. PubMed ID: 12942095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.